[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-422984-105":59,"doc-detail-422984-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","balancing-bleeding-and-thrombosis-in-dental-management-of-patients-on-novel-oral-anticoagulants-a-narrative-evidence-synthesis","Balancing Bleeding and Thrombosis in Dental Management of Patients on Novel Oral Anticoagulants - A Narrative Evidence Synthesis","","This narrative review investigates perioperative hemostatic challenges posed by novel oral anticoagulants (NOACs) in dental practice, synthesizing evidence to balance bleeding and thrombotic risks during oral surgical interventions. A structured search across major databases, plus manual review of guidelines and conference proceedings through October 2025, prioritizes trials, cohorts, and consensus documents while excluding isolated case reports. Pharmacokinetic variability, renal function as a key modifier, risk stratification, local hemostatics, interruption timing, emergency reversal agents, and multidisciplinary planning are analyzed, while noting limited randomized dental-specific data and heterogeneous bleeding endpoints.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/balancing-bleeding-and-thrombosis-in-dental-management-of-patients-on-novel-oral-anticoagulants-a-narrative-evidence-synthesis/422984/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/balancing-bleeding-and-thrombosis-in-dental-management-of-patients-on-novel-oral-anticoagulants-a-narrative-evidence-synthesis/422984.png","ImageObject",300,407,{"name":92,"@type":93},"dawugda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-28",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the focus of this narrative evidence synthesis in dental NOAC management?","Question",{"text":112,"@type":113},"It synthesizes evidence on strategies to balance perioperative bleeding and thrombotic risks during dental oral surgery in patients taking novel oral anticoagulants.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does renal function influence perioperative NOAC decision-making?",{"text":117,"@type":113},"Pharmacokinetic variability across NOACs, with renal function emerging as a critical modifier, guides precise timing for dose omission when interruption is considered.",{"name":119,"@type":110,"acceptedAnswer":120},"What approaches are recommended to control bleeding for minor versus moderate-to-high risk dental procedures?",{"text":121,"@type":113},"Evidence supports uninterrupted anticoagulation for minor procedures when paired with local hemostatics, while moderate-to-high risk surgeries may use trough-timed interruptions combined with minimally invasive techniques.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},422984,1790705202,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},3985747870947,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review began 11/16/2025  \nReview ended 11/25/2025  \nPublished 12/03/2025  \n© Copyright 2025  \nChoudhary et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CCBY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.98373  \nOpen Access Review Article  \nBalancing Bleeding and Thrombosis in Dental Management of Patients on Novel Oral Anticoagulants: A Narrative Evidence Synthesis  \nRama Shankar Choudhary 1, Nishit Kumar 2, Mridu Dubey 1, Ballamudi Sarat Ravi Kiran 1  \n1. Department of Dentistry, Tata Main Hospital, Jamshedpur, IND 2. Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Jamnagar, IND  \nCorresponding author: Rama Shankar Choudhary, [drramashankar81@gmail.com](drramashankar81@gmail.com)  \nAbstract  \nThis narrative review explored the perioperative hemostatic challenges posed by novel oral anticoagulants (NOACs) in dental practice, synthesizing evidence on strategies to equilibrate bleeding and thrombotic risks during oral surgical interventions. A structured literature search across major databases, supplemented by manual searching of guidelines and conference proceedings from inception up to October 2025, prioritized high-quality trials, cohorts, and consensus documents while excluding isolated case reports. Pharmacokinetic variability among agents, such as rapid renal clearance of dabigatran versus mixed hepaticbiliary pathways for factor Xa inhibitors, guides precise timing of dose omission, with renal function emerging as a critical modifier. Risk stratification integrates thrombotic propensity via clinical scoring with procedural bleeding potential and classifies interventions from low (supragingival scaling) to high (extensive flap surgery) . Evidence robustly supports uninterrupted anticoagulation for minor procedures when paired with local hemostatics; topical tranexamic acid, absorbable matrices, and primary closure effectively contain postoperative oozing. Moderate-to high-risk surgeries benefit from trough-timed interruptions, typically one skipped dose for twice-daily agents and two for once-daily, combined with minimally invasive techniques including flapless implantology, piezoelectric osteotomy, and laser coagulation. Reversal agents, including idarucizumab for dabigatran and andexanet alfa for apixaban, edoxaban, and rivaroxaban, remain emergency-only tools because of their logistical and prothrombotic constraints. Multidisciplinary preoperative consultation refines decisions in complex cases. Despite consistent observational safety signals, randomized dental-specific data are limited, bleeding definitions are heterogeneous, and the long-term thrombotic consequences of brief pauses are underexplored. Real-worldconfounders, such as renal decline, polypharmacy, and inflammation, are underrepresented. Nonetheless, this narrative review enables safe continuation in most scenarios, minimizing morbidity through pharmacokinetic awareness, local hemostatic rigor, and surgical conservatism. Future prospective registries with standardized outcomes are essential to validate interruption thresholds and adjunctive modalities in this expanding anticoagulation population.  \nCategories: Dentistry  \nKeywords: dentistry, direct acting oral anticoagulant, hemorrhage, review, thrombosis  \nIntroduction And Background  \nThe introduction of novel oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), has transformed the management of thromboembolic disorders, including nonvalvular atrial fibrillation, venous thromboembolism, and secondary prevention following orthopedic surgery [1] . These agents, including the direct thrombin inhibitor dabigatran and the factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, provide several advantages over traditional vitamin K antagonists, such as warfarin. ","cbCaii6VxWLIgd4Q","https://ap.wps.com/l/cbCaii6VxWLIgd4Q","pdf",765401,"English","# Abstract\n# Introduction And Background\n## How to cite this article","[{\"question\":\"What is the focus of this narrative evidence synthesis in dental NOAC management?\",\"answer\":\"It synthesizes evidence on strategies to balance perioperative bleeding and thrombotic risks during dental oral surgery in patients taking novel oral anticoagulants.\"},{\"question\":\"How does renal function influence perioperative NOAC decision-making?\",\"answer\":\"Pharmacokinetic variability across NOACs, with renal function emerging as a critical modifier, guides precise timing for dose omission when interruption is considered.\"},{\"question\":\"What approaches are recommended to control bleeding for minor versus moderate-to-high risk dental procedures?\",\"answer\":\"Evidence supports uninterrupted anticoagulation for minor procedures when paired with local hemostatics, while moderate-to-high risk surgeries may use trough-timed interruptions combined with minimally invasive techniques.\"}]","Balancing Bleeding and Thrombosis in Dental Management of Patients on Novel Oral Anticoagulants - A Narrative Evidence Synthesis | PDF",1790629595,23]